椎基底动脉延长扩张症伴与不伴卒中患者的基质金属蛋白酶-2和基质金属蛋白酶-9血清水平:病例对照研究
病例对照研究纳入19例椎基底动脉延长扩张症(VBD)患者、14例对照及33例卒中患者(其中14例无VBD、19例伴VBD),检测血清MMP-2和MMP-9并行非增强CT评估。VBD以基底动脉直径≥4.5 mm诊断。伴VBD的两组血清MMP-9均高于对照组和无VBD卒中组,且MMP-9与基底动脉及左椎动脉直径相关。
要点
- VBD诊断标准为基底动脉直径≥4.5 mm,于脑桥中部层面测量颅内椎动脉和基底动脉。
- 伴VBD的两组血清MMP-9均高于对照组和无VBD卒中组,且不依赖卒中状态。
- 血清MMP-9与基底动脉直径(r=0.344,p=0.01)和左椎动脉直径(r=0.305,p=0.05)显著相关。
核心结论
- 高血清MMP-9水平与VBD相关且不依赖卒中,并与VBD程度相关。
研究设计与样本
- 病例对照研究,共66例,平均年龄57.6±16.0岁,41%女性;从门诊招募14例对照和19例VBD患者,从两个急诊科招募33例卒中患者(14例无VBD,19例伴VBD);所有患者行血清MMP-2、MMP-9检测和非增强CT扫描。
关键影像表现/征象
- 于脑桥中部层面评估颅内椎动脉和基底动脉,基底动脉直径≥4.5 mm诊断为VBD。
- 33例卒中患者中位NIHSS为8(范围15),两组卒中患者NIHSS评分无差异。
诊断标准与关键数值
- VBD诊断标准:基底动脉直径≥4.5 mm。
- 伴VBD的两组血清MMP-9均高于对照组和无VBD卒中组;两组卒中患者MMP-9均高于对照组,但与VBD患者无统计学差异。
- 无VBD卒中组中位MMP-2水平低于对照组。
- 血清MMP-9与基底动脉直径相关(r=0.344,p=0.01),与左椎动脉直径相关(r=0.305,p=0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To describe the differences in the serum levels of MMP-2 and MMP-9 of patients with vertebrobasilar dolichoectasia (VBD) with and without acute stroke.
METHODS: Case-control study. From an outpatient clinic, we recruited 14 controls and 19 patients with VBD. We also recruited 33 patients with stroke from two emergency departments, 14 without VBD (S/-VBD) and 19 with VBD (S/ + VBD). All the patients underwent serum MMP-2 and MMP-9 measurements and a non-contrast CT scan. Two investigators assessed the intracranial vertebral arteries (VA) and the basilar artery (BA) at the mid-pons. Diagnosis of VBD was made if the BA diameter was ≥ 4.5 mm.
RESULTS: The mean age of the 66 patients studied was 57.6 + 16.0 years, 41% female. In the 33 patients with stroke, the median NIHSS was 8 (range 15); there were no differences in the NIHSS scores between both groups with stroke. Median MMP-2 levels were lower in the S/-VBD when compared to controls. Median MMP-9 serum levels were higher in both groups with VBD when compared to controls and the S/-VDB group. Both groups with stroke exhibited higher MMP-9 serum levels than controls but were not statistically different from those found in patients with VBD. Serum levels of MMP-9 were significantly correlated with the diameters of the BA (r = 0.344, p = 0.01) and the left VA (r = 0.305, p = 0.05).
CONCLUSION: This study found that high serum levels of MMP-9 are associated with VBD independently of stroke and correlated with the degree of VBD.
引用
- Marquez-Romero, Díaz-Molina, Hernández-Curiel, et al. Matrix metalloproteinase-2 and matrix metalloproteinase-9 serum levels in patients with vertebrobasilar dolichoectasia with and without stroke: case-control study. Neuroradiology. 2021. PMID: 34845504. doi:10.1007/s00234-021-02869-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。